Trigeminal Neuralgia Clinical Trial
Official title:
The Use of Tx360™ Nasal Applicator for Sphenopalatine Ganglion Block in the Treatment of Trigeminal Neuralgia
The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily
function and reduces quality of life. The sphenopalatine ganglion, located in the posterior
part of the middle nasal turbinate, is involved in the pain associated to TN, by blocking the
sphenopalatine ganglion relieves patients from the symptoms. However, methods currently in
use to accomplish this are either cumbersome for the patient or invasive regarding the
puncture of structures.
The purpose of this study is to evaluate the efficacy of Tx360™, a new nasal applicator
device, in the treatment of TN. A local anesthetic will be delivered on the ganglion area. We
are expecting that this new device will provide at least the same pain relief as the
previously described approaches. However, this nasal applicator is intended to be an easy and
non invasive method for office use.
The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily
function and reduces quality of life. Pain severity correlates with reduced measures of daily
functioning, and overall health status.
The sphenopalatine ganglion, located in the posterior part of the middle nasal turbinate, is
involved in the pain associated to TN, by blocking the sphenopalatine ganglion relieves
patients from the symptoms. However, methods currently in use to accomplish this are either
cumbersome for the patient or invasive regarding the puncture of structures.
The purpose of this study is to evaluate the efficacy of Tx360™, a new nasal applicator
device, in the treatment of TN. The Tx360™ is a single use nasal applicator that can reach
the sphenopalatine ganglion area. It is designed to dispense medications through a flexible
canula.
The patients with TN will receive a 0.5 mL spray of local anesthetic on the ganglion area,
and measure the change in pain intensity and quality of life.
We are expecting that this new device will provide at least the same pain relief as the
previously described approaches. However, this nasal applicator is intended to be an easy and
non invasive method for office use.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05152368 -
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy
|
Phase 1 | |
Recruiting |
NCT02801630 -
An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia
|
N/A | |
Completed |
NCT02473016 -
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
|
Phase 2 | |
Recruiting |
NCT01364259 -
A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
|
Phase 3 | |
Completed |
NCT01364272 -
Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
|
||
Completed |
NCT00603694 -
Hippocampal Radiation Exposure and Memory
|
N/A | |
Completed |
NCT00913107 -
Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia
|
Phase 2/Phase 3 | |
Recruiting |
NCT04996199 -
Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial
|
Phase 4 | |
Completed |
NCT06240494 -
Predictive Factors in Maxillary and Mandibular Nerve Radiofrequency Treatment for Trigeminal Neuralgia
|
||
Completed |
NCT05712993 -
Comparative Study Between Transcoronoid and Infrazygomatic Anterior Maneuvers
|
N/A | |
Completed |
NCT04371575 -
Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients
|
||
Completed |
NCT03669744 -
Regional Anesthesia in Refractory Trigeminal Neuralgia: 21 Cases Reported to the Limoges University Hospital
|
||
Completed |
NCT05032573 -
Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia
|
N/A | |
Recruiting |
NCT05615714 -
Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04054024 -
Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia
|
Phase 2 | |
Not yet recruiting |
NCT05451251 -
Deep Brain Stimulation for Refractory Trigeminal Neuralgia With a Demyelinating Pontine Lesion
|
N/A | |
Withdrawn |
NCT04353505 -
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
|
Phase 1 | |
Withdrawn |
NCT01932255 -
CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
|
N/A | |
Completed |
NCT05075707 -
Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia
|
N/A | |
Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 |